Secretory leukocyte protease inhibitor:
β
Nancy R Shine; Susan C Wang; Krystyna Konopka; Elizabeth A Burks; Nejat DΓΌzgΓΌneΕ
π
Article
π
2002
π
Elsevier Science
π
English
β 150 KB
The ability of the salivary protein, secretory leukocyte protease inhibitor (SLPI), to inhibit human immunodeficiency virus-1 (HIV-1) infection in vitro has been reported previously and has led to the suggestion that SLPI may be partially responsible for the low oral transmission rate of HIV-1. Howe